U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential

Madrigal Pharmaceuticals

Market Cap: US$12.1b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Insmed

Market Cap: US$31.2b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Ionis Pharmaceuticals

Market Cap: US$12.4b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Alnylam Pharmaceuticals

Market Cap: US$41.2b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Ascendis Pharma

Market Cap: US$14.3b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

Neurocrine Biosciences

Market Cap: US$13.2b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

BeOne Medicines

Market Cap: US$34.6b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

BridgeBio Pharma

Market Cap: US$14.4b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

AbbVie

Market Cap: US$354.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Jazz Pharmaceuticals

Market Cap: US$12.5b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Eli Lilly

Market Cap: US$824.6b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Natera

Market Cap: US$29.4b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Royalty Pharma

Market Cap: US$29.5b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Viatris

Market Cap: US$16.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Elanco Animal Health

Market Cap: US$11.2b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$10.5b

Provides health sciences solutions, technologies, and services.

BioMarin Pharmaceutical

Market Cap: US$10.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Waters

Market Cap: US$32.8b

Provides analytical workflow solutions in Asia, the Americas, and Europe.